Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2017

Feb 21, 2017

33899_dirs_2017-02-21_da16805e-d136-4043-a1b9-20a4d2fe0390.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2017-02-16

Reporting Person: KELLEMAN JOSEPH P (Vice President of Finance)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-16 Stock Option $44.73 A 1250 Acquired 2027-02-16 Common Stock (1250) Direct

Footnotes

F1: These non qualified stock options, which were issued to the reporting person under the 2012 Share Incentive Plan, will vest in three equal annual installments beginning on the first anniversary of the grant date.